Table of Contents
Mapping the Market for Investment, Best Practices, and Growth Potential
The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and provides an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies. The infectious disease IVD market in Indonesia can be divided into segments such as microbiology testing, immunochemistry testing, and molecular diagnostics testing. The study covers the period 2012 to 2017.
-The Indonesian infectious disease in-vitro diagnostics (IVD) market is expected to grow from $ million in 2012 to $ million in 2017 at a compound annual growth rate (CAGR) of %.
-Infectious disease market is one of the largest segments in terms of volume and constitutes approximately % of total IVD market in Indonesia.
-Multinational companies continue to dominate the market by making an early entry in the molecular diagnostics segment, and this trend is predicted to continue. The combined market share of MNCs is approximately two-third of total market.
-The main challenge in Indonesia’s infectious disease IVD market is accurately identifying, diagnosing, and reporting infectious diseases due to a shortage of skilled healthcare workers and laboratory facilities to ensure accurate diagnosis.
-The government provides a favourable policy environment for the infectious disease participants in the form of investment in primary healthcare system, public hospital reforms, encouragement of IVD-related technology innovation for local participants, and improved reimbursement policy.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...
Global Point-of-Diagnostics Market: Overview Point-of-care diagnostics is carried out in the clinics, home or near patient locations for testing of a sample from a patient in order to facilitate a prompt ...
With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach ...